OneCell Diagnostics is now 1Cell.Ai

Contact

1Cell ERA Newsletter | December 2025

This edition highlights key advances in precision oncology from SABCS 2025, focusing on breast cancer, emerging biomarkers, AI-driven risk stratification, and real-time monitoring through liquid biopsy. It also features TRINITY AI by 1Cell.Ai, showcasing how AI-enabled, multi-modal analysis can support smarter treatment decisions and help reduce overtreatment while improving patient outcomes.

Download Newsletter
Close
1Cell.Ai
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.